To define and monitor the state of the art and emerging technologies in clinical microbiology, to contribute to development, maintenance, and enhancement of CAP clinical microbiology proficiency testing and other quality assurance programs; to provide information and expertise in clinical microbiology to the College for furtherance of its programs; and to maintain liaison, where appropriate, with other national and global organizations concerned with clinical microbiology.
Current Susceptibility Breakpoints
- Clinical and Laboratory Standards Institute
- FDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria
- European Committee on Antimicrobial Susceptibility Testing
2023 Breakpoints In Use Toolkit
Effective January 2024, clinical laboratories performing antimicrobial susceptibility testing (AST) will be required to use breakpoints currently recognized by Clinical and Laboratory Standards Institute (CLSI) or US Food and Drug Administration (FDA). Visit the 2023 Breakpoint Implementation Toolkit (2023 BIT) for more information.
Highlighted Organism Discussion
Discussion on Staphylococcus schleiferi
- Staphylococcus schleiferi is an increasingly encountered zoonotic pathogen that colonizes the skin and mucosal membranes of small animals, including dogs.
- Due to β-hemolysis on blood agar and variable positivity by coagulase tests (eg, slide, tube and latex agglutination methods), misidentification of S. schleiferi as S. aureus or other Staphylococcus species can occur.
- MALDI-TOF MS is a reliable method to identify and differentiate S. schleiferi from other Staphylococcus species. Differentiation of staphylococci to the species level is growing increasingly important due to differences in methods and breakpoints applied to detect mecA-mediated oxacillin resistance among staphylococci, including S. schleiferi.
CAP Press Microbiology Publications
The following publication is available for purchase through our CAP Press Publications site.
|Time Commitment Requirements|
|Number of face-to-face meetings||3|
|Length of meetings||2 days|
|Typical meeting days||Friday and Saturday|
|Meeting locations||One meeting is held in Chicago. The others will be held in the continental United States.|
|Number of conference calls||3|
|Hours/year of committee work required outside of meetings||Members 75+, Vice Chair 100+, Chair 150+|
Activities of Committee
- Support the Surveys Microbiology program by selecting specifications, reviewing participant instructions, reviewing participant data and writing on final critique discussions.
- Prepare continuing education questions and material for several Surveys.
- Provide expertise to employee health physicians in cases of Laboratory Accidents.
- Provide expertise to participants who contact the College for information on current microbiology practice.
- Work with laboratory education to develop and update microbiology checklist questions.
Expertise or Experience
- Those with expertise in current microbiology practice in bacteriology, parasitology, virology, mycology, and/or molecular microbiology diagnostics
Benefits of Committee Membership
- Opportunity to work with leaders in the field of microbiology to improve laboratory practice
Representation on Committee Beyond the CAP
- Two Consultants